Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
304.9000 -4.45 (-1.44%)
NSE Aug 04, 2025 10:58 AM
Volume: 7,398
 

304.90
-1.44%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 15.2% YoY to | 257.4 crore (I-direct estimate: | 269.4 crore) mainly due to 18.4% YoY growth in export formulations to | 92.3 crore (I-direct estimates: | 115.6 crore). Domestic formulations grew 12.7% to | 142.1 crore (I-direct estimate: | 130.6 crore) EBITDA margins declined 238 bps YoY to 16.2% (I-direct estimate of 17.9%) mainly on account of an increase in employee expenditure...
Prabhudas Lilladhar increased Hold price target of Indoco Remedies Ltd. to 325.0 on 25 Jul, 2025.
More from Indoco Remedies Ltd.
Recommended